Product Name :
Palomid 529 (P529)
CAS No.:
914913-88-5
Purity :
> 99%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
COC1=CC=C(COC2=C(OC)C=C3C(=C2)OC(=O)C4=C3C=CC(=C4)C(C)O)C=C1
Product Description :
Palomid 529 (P529) inhibits both the mTORC1 and mTORC2 complexes, reduces phosphorylation of pAktS473, pGSK3βS9, and pS6 but no effect observed on pMAPK or pAktT308. Phase 1.
Formula:
C24H22O6
Molecular Weight :
406.43
Synonyms:
SG 00529
Additional Information:
|CAS No. 914913-88-5 ; |Synonyms SG 00529 ; |Formula C24H22O6 ; |Molecular Weight 406.{{Cabergoline} medchemexpress|{Cabergoline} Autophagy|{Cabergoline} Biological Activity|{Cabergoline} Data Sheet|{Cabergoline} custom synthesis|{Cabergoline} Cancer} 43 ; |SMILES COC1=CC=C(COC2=C(OC)C=C3C(=C2)OC(=O)C4=C3C=CC(=C4)C(C)O)C=C1 ; |Target mTOR ; |Product Description Palomid 529 (P529) inhibits both the mTORC1 and mTORC2 complexes, reduces phosphorylation of pAktS473, pGSK3βS9, and pS6 but no effect observed on pMAPK or pAktT308.{{Cinacalcet} MedChemExpress|{Cinacalcet} CaSR|{Cinacalcet} Protocol|{Cinacalcet} References|{Cinacalcet} custom synthesis|{Cinacalcet} Autophagy} Phase 1.PMID:24580853 ; |Purity > 99% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO